Coherent Marketplace Insights says the joint pain injections marketplace measurement will reach $9.46 billion by 2031, growing at a CAGR of 8.7%.

The joint pain injections market is estimated to be valued at US$5.29 billion in 2024 and is predicted to show a CAGR of 8.7% during the forecast period 2024-2031, as per a latest file published by Coherent Marketplace Insights. Lined Companies: Pfizer, Inc., Ferring Prescribed Drugs Inc., Pacira Biosciences, Eli Lilly & Corporate, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Sanofi, Anika Therapeutics, Inc., Bioventus, Dr. Reddy’s Laboratories Ltd., Zimmer Biomet, Ferring B.V., Seikagaku Corporation, and Ono Pharmaceutical Co., Ltd.

BURLINGAME, July 16, 2024 (GLOBE NEWSWIRE) — Worldwide joint pain injections market The size is estimated to be US$5.29 billion in 2024 and is projected to reach US$9.46 billion at a CAGR of 8.7% during the forecast period to 2031, as per the latest study through Coherent Marketplace Insights., Expanding the availability of magazines and complex injectable drugs for joint pain. Continuous research and manufacturing by pharmaceutical companies has resulted in the creation of injectable medicine with advanced efficacy, long duration of action and mild side effects.

Get the pattern page: https://www.coherentmarketinsights.com/insight/request-sample/6939

Market Dynamics:

The joint pain injections market is fundamentally driven by the emerging geriatric folk world. According to WHO, the number of elderly people over the age of 65 is expected to increase from 703 million in 2019 to 1.5 billion by 2050. Adults are more likely to suffer from joint pain due to arthritis and other joint-related conditions. , This is boosting the demand for joint injections for pain control. Furthermore, developments in injectable products combined with minimally invasive procedures for extended efficacy and pain relief are also contributing to the expansion of the market.

Market Development:

Increasing Desire for Hyaluronic Acid Injections: Hyaluronic acid injections are widely used joint pain injections, which have benefits such as long-lasting pain relief and joint lubrication for 6-365 days. This makes them the most popular choice compared to alternative injections and is enjoying significant market demand.

Joint Pain Injections Marketplace File Security

Emerging appreciation for stem cellular therapies: Emerging stem cell therapies that use mesenchymal stem cells extracted from bone marrow, adipose tissue, or alternative tissues show potential in treating degenerative joint diseases by repairing cartilage and reducing inflammation. . Continuous analysis to strengthen their efficacy is anticipated to burden new options available in the market.

the story continues

To get complete file research: https://www.coherentmarketinsights.com/insight/buy-now/6939

Market Options:

In steroid joint injections, corticosteroids are injected immediately into the hollow space of the joint. Corticosteroids help reduce pain and inflammation by blocking the production of prostaglandins. They are very effective for providing temporary relief from pain related to osteoarthritis or other joint problems. Steroid injections are routinely given to treat pain in the knee, shoulder, hip, elbow and wrist joints. Because they are rapid-discharge, steroid joint injections are one of the most common minimally invasive treatment options for joint pain.

Hyaluronic acid injections involve injecting hyaluronic acid immediately into the affected joint. Hyaluronic acid is a herbal lubricant that helps reduce friction within joints. It additionally promotes the repair of injured joint tissues. Hyaluronic acid injections are suitable for treating pain caused by osteoarthritis because they supplement the fluid that lubricates the joints. They have fewer side effects than corticosteroids and can provide pain relief for a longer period of time, up to 6 months. As such, hyaluronic acid injections are gaining popularity as an efficient backup to steroid injections.

Market highlights:

Due to increasing aging population and rising incidence of osteoarthritis and rheumatoid arthritis, the worldwide joint pain injections market is expected to witness a CAGR of 8.7% during the estimated period of 2024-2031.

On the basis of injection type, the steroid joint injection segment is expected to maintain a dominant position, accounting for more than 30% market share due to their quick pain relieving effects. Within this section, injections are most frequently given in the knee and shoulder.

By way of utility, the knee and ankle segment is predicted to dominate the market due to the high prevalence of knee osteoarthritis. Knee joints bear excessive weight of the body and with the passage of time, there is a risk of their breakage.

Locally, the United States is predicted to dominate the joint pain injections market by 2031, due to rising weight problems and increasing population of older people in the United States and Canada, increasing the burden of joint problems. .

Major players operating in the joint pain injections market include Zimmer Biomet, Anika Therapeutics, Inc., Bioventus LLC, Ferring BV, Sekagaku Company, Chugai Pharmaceutical Co., Ltd., etc. They are gamers who specialize in new product launches and geographic expansion to strengthen their market position.

Request for Customization: https://www.coherentmarketinsights.com/insight/request-customization/6939

Contemporary Trends:

In March 2022, Green Roads, a subsidiary of Valence Corporate, donated US$120,000 to the Arthritis Understructure to aid the group’s pain control initiative to conduct a week-long nature trip for people with persistent pain. This donation made Green Roads a legitimate supporting sponsor of Arthritis Infrastructure.

In January 2022, AbbVie won USA Food and Drug Management (FDA) approval for Skyriz (risankizumab-arza) for the treatment of adults with active psoriatic arthritis (PsA), which can also be administered with a single injection four times a day. can be done.

Striking Division:

Sort by injection:

Via combined sort:

• knee and ankle

• hip joint

• hand and wrist

• Option

Through distribution channel:

• sanatorium pharmacies

• retail pharmacies

• on-line pharmacies

Through the field:

north united states,

latin united states,

• brazil

• argentina

• Mexico

• remains of latin united states

Europe,

• Germany

• U.Ok.

• spain

• France

• Italy

• Russia

• remains of europe

Asia Pacific,

• China

• Republic of India

• Japan

• Australia

• South Korea

• asean

• remains of asia pacific

heart east,

• gcc international location

• israel

• remains of heart east

Africa,

• South Africa

• North Africa

• Central Africa

Browse additional trending experiences:

Complex Regional Pain Syndrome Market: The worldwide complex regional pain syndrome market is segmented by disease type (CRPS I, CRPS II, and CRPS-NOS), by drug type (T-121, NTRX-07, neridronic acid and others). Distribution channels (sanatorium pharmacies, retail pharmacies, on-line pharmacies, and others)

Traditional Pain Control Market: Worldwide Interventional Pain Control Market, by Method (Pain Control Injections (Epidural Steroid Injection, Side Joint Injection, Medial Segment Block, Nerve Block, Sacroiliac Injection, Causal Level Injection, and Others), Radiofrequency Ablation, Spinal Twin Stimulation, and Others) , by way of utility (back and neck pain, diabetic neuropathy, cancer pain, structure loss and ankle pain, joint pain, muscle pain and cramps, post-traumatic pain, shingles pain, and others)

about us:

Coherent Marketplace Insights is a global market perception and consulting group that provides syndicated analysis studies, custom designed analysis studies and consulting products and services. We are known for our actionable insights and original studies in various domain names including Aerospace & Defence, Agriculture, Food & Beverage, Car, Chemical Compounds & Clothing, and a detailed record of almost all domain names and sub-domains below. Solar. We determine the prices for the buyers through our extremely thorough and accurate studies. We are also dedicated to enjoying the post-COVID-19 situation of providing insights across sectors and moving forward to bring measurable, sustainable impact to our buyers.

Website Online: https://www.coherentmarketinsights.com

CONTACT: Mr. Shah Senior Shopper Spouse – Industry Construction Coherent Marketplace Insights Telephone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 Republic of India: +91-848-285-0837 Electronic mail: gross sales@coherentmarketinsights.com